Clinical trial · Observational
Dental Safety Profile of High-Dose Radioiodine Therapy
The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer
NCT00439478CI-TRIAL-00000970completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
We aim to assess the incidence of oral and dental adverse events after high-dose radioiodine therapy for differentiated thyroid cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Thyroid Cancer | Malignant Thyroid Gland Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Radioiodine | Drug | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * histologically confirmed differentiated thyroid cancer * status after total thyroidectomy * status after subsequent high-dose radioiodine treatment * regular follow-up by a board-certified dentist * a minimum follow-up of 1 year after radioiodine therapy. Exclusion Criteria: * anaplastic thyroid cancer
References
Publications (0)
Data not yet available
No reference posted for this study.